{"entity":{"id":"nct04974008","kind":"trial","name":"Osteosarcoma Maintenance Therapy With OST31-164","aka":[],"tldr":"A phase 2 trial of OST31-164 in advanced solid tumours, run by Emerald Clinical Inc., active and no longer recruiting.","summary":"Osteosarcoma Maintenance Therapy With OST31-164 is a phase 2 interventional study registered as NCT04974008 by Emerald Clinical Inc., with 39 participants enrolled, started 2021-10-21 and due to reach its primary completion in 2023-09-21. Interventions recorded: OST31-164.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04974008","url":"https://clinicaltrials.gov/study/NCT04974008"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04974008","phase":"2","setting":"An Open-Label Phase 2 Study of Maintenance Therapy With OST31-164 After Resection of Recurrent Osteosarcoma","sponsor":"Emerald Clinical Inc.","enrolled":39,"outcomes":[]},"route":"/trials/nct04974008/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}